A randomized, double-blind, placebo-controlled phase 2 study to assess safety, tolerability, and efficacy of RT001 in patients with amyotrophic lateral sclerosis

Daphne N. Weemering, Mark Midei, Peter Milner, Vidhya Gopalakrishnan, Anil Kumar, Andrew J. Dannenberg, Tommy M. Bunte, Juliette Foucher, Caroline Ingre, Viktorija Ķēniņa, Karin Rallmann, Leonard H. van den Berg, Ruben P.A. van Eijk (Corresponding Author)

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'A randomized, double-blind, placebo-controlled phase 2 study to assess safety, tolerability, and efficacy of RT001 in patients with amyotrophic lateral sclerosis'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science